Kiniksa Pharmaceuticals International Statistics
NASDAQ: KNSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
79.80+1.04 (+1.33%)
Market open · Delayed 15 min · as of Oct 9, 10:07 AM ET
Kiniksa Pharmaceuticals International by the numbers
Kiniksa Pharmaceuticals International has a market capitalization of $6.23 billion based on 48.29M shares outstanding. Its trailing P/E ratio is 80.6, and its forward P/E is 49.3. The stock trades 3.0% above its 50-day average and 40.2% above its 200-day average.
Average daily trading volume is 573.74K shares, or about $45.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KNSA valuation vs. peer median
| Metric | KNSA | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.23B | $5.74B | +8% |
| Forward P/E | 49.3 | 25.8 | +91% |
| Avg. volume | 573.74K | 737.58K | -22% |
Peer median across 8 companies: BLTE, LGND, RYTM, MIRM, ERAS, MANE, ALKS, PTCT.
Valuation
- Market cap
- $6.23B
- P/E (TTM)
- 80.60
- Forward P/E
- 49.33
- Price / sales (latest FY)
- 9.19
- EPS (TTM)
- $0.99
- Shares outstanding
- 48.29M
Price and trading
- Previous close
- 78.75
- Open
- 78.24
- Day range
- 78.23 – 79.98
- 52-week range
- 35.20 – 82.94
- 52-week change
- +105.56%
- Beta
- —
- Volume
- 26.63K
- Average volume
- 573.74K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 27, 2026
Additional statistics
- Market Cap
- 6.23B
- Pe
- 80.60
- Forward Pe
- 49.33
- Eps
- 0.99
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 82.94
- Week52 Low
- 35.20
- Avg Volume
- 573.74K
- Shares Outstanding
- 48.29M
- Ma50
- 77.47
- Ma200
- 56.92
- Earnings Date
- Oct 27, 2026
- Pct From52w High
- -3.79%
- Pct From52w Low
- 126.69%